WGb-0301 injection

DRUG2 trials

Sponsors

Sichuan University, West China Hospital

Conditions

Autoimmune DiseasesB Cell Malignancies

Early Phase 1

Exploratory Study on the Treatment of Relapsed and Refractory B-cell Malignant Tumors With WGb-0301 Injection

Not yet recruitingNCT07332663

Sichuan UniversityB Cell Malignancies

Start: 2026-01-01End: 2028-12-31Target: 9Updated: 2026-01-12

Exploratory Study on the Treatment of Relapsed and Refractory Immune Related Diseases With WGb-0301 Injection

Not yet recruitingNCT07349823

West China HospitalAutoimmune Diseases

Start: 2026-01-26End: 2028-12-31Target: 47Updated: 2026-01-20